Cellnovo Partners with US Company TypeZero on Artificial Pancreas Programme
For further information please visit www.cellnovo.com
About the Cellnovo Diabetes Management System
Compact, tubeless, intuitive and entirely connected, Cellnovo’s insulin pump comprises a mobile touchscreen controller with an integrated blood-glucose meter. This unique device allows optimal management of insulin injections with drop-by-drop precision, whilst ensuring extensive freedom of movement and peace of mind for patients. Thanks to the automatic transmission of data, it also allows the patient’s condition to be continually monitored by family members and healthcare professionals in real-time.
About TypeZero Technologies
Headquartered in Charlottesville, Virginia, USA, TypeZero Technologies is a digital health and technology company specializing in software and analytics whose mission is to revolutionize the way the world treats and manages diabetes. TypeZero Technologies applies data-driven analyses and modern engineering practices to develop personalized analytics and control solutions based on proven metabolic models to help people with type 1 and type 2 diabetes improve their health reduce the stress of daily diabetes management, and reduce overall treatment costs. The company’s products include mobile minute-by-minute closed-loop control of blood glucose (inControl Artificial Pancreas), cloud-based predictive analytics, smart bolus calculators, and clinician tools for therapy optimization. TypeZero Technologies is a rapidly growing private company currently backed by angel investors and early stage venture capital.
To learn more, visit www.TypeZero.com.
